Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Fourth Dimension Solutions IPO and Ganga Pharmaceuticals IPO.
Fourth Dimension Solutions IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Ganga Pharmaceuticals IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Sarthi Capital Advisors Private Limited | First Overseas Capital Limited |
| Registrar | Sharepro Services Private Limited | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | ||
| RHP | RHP  |
|
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Fourth Dimension Solutions IPO is up to ₹8.68 Cr whereas the issue size of the Ganga Pharmaceuticals IPO is up to ₹1.54 Cr. The final issue price of Fourth Dimension Solutions IPO is ₹30.00 per share and of Ganga Pharmaceuticals IPO is ₹15.00 per share.
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹30.00 per share | ₹15.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 8000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 28,92,000 shares | 10,24,000 shares |
| Issue Size Total (Amount) | up to ₹8.68 Cr | up to ₹1.54 Cr |
Fourth Dimension Solutions IPO opens on Dec 30, 2015, while Ganga Pharmaceuticals IPO opens on Jan 29, 2016. The closing date of Fourth Dimension Solutions IPO and Ganga Pharmaceuticals IPO is Jan 07, 2016, and Feb 09, 2016, respectively.
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Dec 30, 2015 | Jan 29, 2016 |
| Issue Close | Jan 07, 2016 | Feb 09, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Fourth Dimension Solutions IPO P/E ratio is , as compared to Ganga Pharmaceuticals IPO P/E ratio of .
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Fourth Dimension Solutions IPO retail investors (RII) are offered while in Ganga Pharmaceuticals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Fourth Dimension Solutions IPO and in Ganga Pharmaceuticals IPO.
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Fourth Dimension Solutions IPO subscribed in total, whereas Ganga Pharmaceuticals IPO subscribed .
| Fourth Dimension Solutions IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
